Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan-amoxicillin dual therapy for Helicobacter pylori rescue treatment
ChiCTR2200066010Phase 4Not yet recruiting
- Sponsor
- Eighth Affiliated Hospital of Sun Yat-sen University
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tegoprazan and amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Eighth Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Hp eradication rate. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
tegoprazanamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2200066010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066010.